FSA Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FSA Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$10K	Hold	100	–	–	﹤0.01%	306
2025 Q2	$8.29K	Sell	100 -202	-67%	-$16.1K	﹤0.01%	321
2025 Q1	$24.5K	Sell	302 -447	-60%	-$40K	0.01%	204
2024 Q4	$67.5K	Hold	749	–	–	0.03%	121
2024 Q3	$74K	Buy	+749	New	+$73.6K	0.03%	120
2024 Q1	$71.1K	Hold	749	–	–	0.03%	113
2023 Q4	$67K	Buy	+749	New	+$55.6K	0.03%	111
2021 Q1	–	Sell	-227	Closed	-$32K	–	246
2020 Q4	$32K	Buy	+227	New	+$29.1K	0.02%	164
2020 Q3	–	Sell	-227	Closed	-$25K	–	367
2020 Q2	$25K	Hold	227	–	–	0.02%	178
2020 Q1	$18K	Hold	227	–	–	0.02%	192
2019 Q4	$22K	Buy	+227	New	+$19.6K	0.02%	221

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

FSA Wealth Management's XBI Position: Q3 2025 in Review

FSA Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2025 at 100 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

FSA Wealth Management first reported a position in XBI in Q4 2019 and has held it in 11 quarters since. The position peaked at $74K in Q3 2024. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

FSA Wealth Management held 100 shares of State Street SPDR S&P Biotech ETF worth $10K as of Q3 2025.
FSA Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2025.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #306 holding.
FSA Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 11 quarters since.
FSA Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $74K in Q3 2024.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.